| CRISPR/CAS-related methods and compositions for treatment of beta … |
2023-8-08 |
2023-8-31 |
|
| CRISPR-CPF1-related methods, compositions and components for cancer … |
2023-3-23 |
2023-6-27 |
|
| Use of exonucleases to improve CRISPR/Cas-mediated genome editing |
2023-1-31 |
2023-4-27 |
|
| Systems and methods for one-shot guide rna (ogrna) targeting of endogenous and … |
2022-12-26 |
2023-4-11 |
|
| Engineered crispr/cas12a effector proteins, and uses thereof |
2022-11-28 |
2023-6-01 |
|
| CRISPR/CAS-related methods and compositions for treating herpes simplex virus |
2022-11-14 |
2023-3-02 |
|
| Methods of assessing nuclease cleavage |
2022-11-04 |
2022-12-22 |
|
| Selection by essential-gene knock-in |
2022-11-02 |
2023-1-01 |
|
| CRISPR/CAS-related methods and compositions for improving transplantation |
2022-10-28 |
2022-12-08 |
|
| Emulsion-based screening methods |
2022-10-04 |
2023-10-05 |
|
| Synthetic guide molecules, compositions and methods relating thereto |
2022-9-26 |
2022-11-18 |
|
| CRISPR RELATED METHOD AND COMPOSITION WITH GOVERNING gRNA |
2022-9-14 |
2022-12-20 |
|
| Treatment of pain |
2022-8-15 |
2023-8-24 |
|
| Genetically engineered cells and methods of making the same |
2022-8-09 |
2022-11-17 |
|
| Systems and methods for the treatment of hemoglobinopathies |
2022-8-02 |
2023-2-09 |
|
| Engineered cells for therapy |
2022-6-23 |
2022-12-29 |
|
| Engineered cells for therapy |
2022-6-14 |
2022-8-01 |
|
| Optimized crispr/cas9 systems and methods for gene editing in stem cells |
2022-6-09 |
2023-4-27 |
|
| Modified cells and methods for the treatment of hemoglobinopathies |
2022-6-07 |
2022-8-01 |
|
| Compositions and methods for treating cep290-associated disease |
2022-5-23 |
2023-9-21 |
|
| Engineered cells for therapy |
2022-5-04 |
2022-11-10 |
|
| Crispr–cas–related methods, compositions and components for cancer … |
2022-4-26 |
2022-6-01 |
|
| Methods for improving crispr/cas-mediated genome-editing |
2022-4-21 |
2022-5-12 |
|
| Crispr/rna-guided nuclease-related methods and compositions for treating rho- … |
2022-4-15 |
2022-10-20 |
|
| Crispr/cas-related methods and compositions for treating leber's congenital … |
2022-3-07 |
2023-1-26 |
|
| Compositions and methods for promoting homology directed repair |
2022-2-17 |
2022-3-10 |
|
| Crispr/cas-mediated gene conversion |
2022-2-15 |
2023-1-19 |
|
| Crispr/cas-related methods and compositions for treating sickle cell disease |
2022-2-07 |
2023-1-26 |
|
| Crispr/cas-related methods, compositions and components |
2022-1-10 |
2023-1-05 |
|
| Cas9 fusion molecules, gene editing systems, and methods of use thereof |
2021-12-20 |
2022-6-16 |
|
| Evaluation of cas9 molecule/guide rna molecule complexes |
2021-11-22 |
2022-10-13 |
|
| Methods of inducing antibody-dependent cellular cytotoxicity (adcc) using … |
2021-10-26 |
2022-5-05 |
|
| Cells expressing a recombinant receptor from a modified tgfbr2 locus, related … |
2021-10-12 |
2021-12-01 |
|
| Compositions and methods for treating cep290-associated disease |
2021-10-11 |
2022-9-01 |
|
| CRISPR-Cas-related methods, compositions and components for cancer … |
2021-9-20 |
2021-10-21 |
|
| Crispr/rna-guided nuclease-related methods and compositions for treating rho- … |
2021-8-17 |
2021-10-31 |
|
| Modified Natural Killer (NK) Cells for Immunotherapy |
2021-8-13 |
2022-4-22 |
|
| Crispr/cas-related methods and compositions targeting virus genomes |
2021-7-29 |
2021-11-25 |
|
| Engineered cas9 nucleases |
2021-7-14 |
2022-6-09 |
|
| Crispr/cas-related methods and compositions for treating usher syndrome and … |
2021-6-07 |
2022-5-05 |
|
| Crispr/cas-related methods and compositions for treating cystic fibrosis |
2021-4-30 |
2021-12-09 |
|
| Compositions and methods for treating cep290-associated disease |
2021-2-02 |
2023-2-09 |
|
| Modified cells and methods for treating hemoglobinopathies |
2020-12-09 |
2022-10-11 |
|
| Systems and methods for the treatment of hemoglobinopathies |
2020-12-08 |
2022-1-27 |
|
| Methods of producing cells expressing a recombinant receptor and related … |
2020-9-30 |
2020-11-30 |
|
| T cells expressing a recombinant receptor, related polynucleotides and methods |
2020-9-30 |
2020-11-30 |
|
| Systems and methods for the treatment of hemoglobinopathies |
2020-9-11 |
2021-8-19 |
|
| Systems and methods for the treatment of hemoglobinopathies |
2020-9-11 |
2022-3-10 |
|
| Systems and methods for the treatment of hemoglobinopathies |
2020-9-04 |
2021-7-29 |
|
| Crispr/cas-related methods and compositions for treating herpes simplex virus ( … |
2020-7-31 |
2020-12-17 |
|
| Crispr-related methods and compositions |
2020-7-24 |
2021-2-11 |
|
| Cpf1-related methods and compositions for gene editing |
2020-6-11 |
2020-9-24 |
|
| Methods, compositions and components for crispr-cas9 editing of tgfbr2 in t … |
2020-4-27 |
2020-6-30 |
|
| Systems and methods for treating hyper-igm syndrome |
2020-4-23 |
2020-6-30 |
|
| Hpv-specific binding molecules |
2020-3-26 |
2020-5-31 |
|
| Methods and compositions for treating cone-rod retinal dystrophy |
2020-2-26 |
2020-4-30 |
|
| Systems and methods for the treatment of hemoglobinopathies |
2019-11-27 |
2022-2-17 |
|
| Crispr/rna-guided nuclease systems and methods |
2019-11-08 |
2020-5-21 |
|
| Systems and methods for the treatment of hemoglobinopathies |
2019-9-12 |
2020-5-21 |
|
| Synthetic guide molecules, compositions and methods relating thereto |
2019-6-28 |
2020-1-02 |
|
| Crispr/cas-related methods and compositions for treating herpes simplex virus |
2019-4-26 |
2019-8-15 |
|
| CRISPR/Cas9-mediated exon-skipping approach for USH2A-associated Usher syndrome |
2019-3-25 |
2020-10-08 |
|
| Systems and methods for modulating chromosomal rearrangements |
2019-1-30 |
2019-8-08 |
|
| Targeted integration systems and methods for the treatment of … |
2018-11-07 |
2019-5-16 |
|
| Methods, compositions and components for crispr-cas9 editing of cblb in t cells … |
2018-11-05 |
2019-5-09 |
|
| Hpv-specific binding molecules |
2018-9-28 |
2023-10-11 |
|
| Systems and methods for targeted integration and genome editing and detection … |
2018-7-13 |
2019-1-17 |
|
| Methods and systems for analyzing guide rna molecules |
2018-4-27 |
2018-11-01 |
|
| Crispr/cas-related methods and compositions for treating hepatitis b virus |
2018-4-20 |
2018-8-23 |
|
| Selection methods |
2018-3-29 |
2021-2-18 |
|
| Nucleic acid mutagenesis methods |
2018-3-29 |
2018-10-04 |
|
| Crispr/cas-related methods and compositions for treating duchenne muscular … |
2018-3-23 |
2018-8-17 |
|
| Synthetic guide molecules, compositions and methods relating thereto |
2017-12-29 |
|
|
| Synthetic guide molecules, compositions and methods relating thereto |
2017-12-29 |
2022-12-23 |
|
| Emulsion-based screening methods |
2017-12-19 |
2021-10-06 |
|
| Assessing nuclease cleavage |
2017-12-19 |
2020-6-18 |
|
| Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and … |
2017-12-05 |
2022-12-23 |
|
| Crispr/cas-related methods and compositions for treating hiv infection and aids |
2017-11-10 |
2018-5-03 |
|
| compositions and methods for treating cep290-associated disease |
2017-8-02 |
2019-7-09 |
|
| Genetically engineered cells and methods of making same |
2017-5-06 |
2023-10-10 |
|
| Crispr/cas-related methods and compositions for treating duchenne muscular … |
2017-5-05 |
2017-11-09 |
|
| Grna fusion molecules, gene editing systems, and methods of use thereof |
2017-4-12 |
2019-2-28 |
|
| Systems and methods for treating alpha 1-antitrypsin (A1AT) deficiency |
2017-3-24 |
2022-11-29 |
2022-11-29 |
| Genome editing systems comprising repair-modulating enzyme molecules and … |
2017-3-24 |
2023-3-07 |
2023-3-07 |
| Crispr/cas-related methods and compositions for treating herpes simplex virus … |
2016-9-30 |
2017-3-16 |
|
| Crispr/cas-related methods and compositions for treating hiv infection and aids |
2016-9-23 |
2017-1-12 |
|
| Crispr/cas-related methods and compositions for treating primary open angle … |
2015-4-01 |
2017-2-02 |
|
| Crispr/cas-related methods and compositions for treating herpes simplex virus … |
2015-4-01 |
2015-10-08 |
|
| Crispr/cas-related methods and compositions for treating beta-thalassemia |
2015-3-26 |
2015-10-01 |
|
| Hpv-spezifische bindungsmoleküle |
2018-9-28 |
2023-10-11 |
|
| Molécules de liaison spécifiques du vph |
2018-9-28 |
2023-10-11 |
|
| 基因工程化细胞及其制备方法 |
2017-5-06 |
2023-10-10 |
|